
Delaying treatment for localised prostate cancer does not increase the risk of death, new research suggests.
According to a new study, active monitoring of the disease has the same high survival rates after 15 years as radiotherapy or surgery.

Delaying treatment for localised prostate cancer does not increase the risk of death, new research suggests.
According to a new study, active monitoring of the disease has the same high survival rates after 15 years as radiotherapy or surgery.